The 9th Meeting of the Scientific and Ethics Committee for the Clinical Study of the F₁ Offspring of A-bomb Survivors was held on Tuesday, November 26. At the meeting, reports were announced on the progress being made in the Clinical Study of the F₁ Offspring of A-bomb Survivors (F₁ Clinical Study) to leading outside experts in various fields such as clinical medicine, basic science, and ethics.

The F₁ Clinical Study aims, first of all, to contribute to the health and welfare of each study participant through health examinations provided at RERF. The study is also tasked with investigating genetic effects of A-bomb radiation such as whether A-bomb radiation exposure affects disease incidence in the offspring of A-bomb survivors and whether any changes are observed in biological samples such as blood and urine provided by the study’s participants.

For more information about the meeting, please click on the following link:

→ Information regarding the 9th meeting of the Scientific and Ethics Committee for the Clinical Study of the F₁ Offspring of A-bomb Survivors